在临床稳定的患者中Lp (a) 的时间变化:对心血管风险评估的影响
Maria G Matta1, Laura Schreier2, Augusto Lavalle-Cobo3
1Department of Pharmacology, Faculty of Medicine, Universidad FASTA, Clinical Researcher at the Clinical Research Institute (IIC), Mar del Plata, Argentina; Cardiology Department, Townsville University Hospital, 100 Angus Smith Dr, Douglas QLD 4814, Australia.
概括
随着时间的推移,脂蛋白 (a) 含量可以显著变化,即使在稳定的患者中也是如此. 这表明,单个测量可能不会准确地反映个人的心血管疾病风险.
科学领域:
- 心血管医学 心血管医学
- 临床化学 临床化学
- 遗传学 是一个遗传学.
背景情况:
- 脂蛋白 (Lp) 是心血管疾病的关键遗传风险因素.
- 目前的指导方针通常建议使用一次生命周期测量,因为感知到的变化最小.
- 在常规的临床评估中,Lp (a) 常常被忽视.
研究的目的:
- 评估临床稳定的患者中脂蛋白水平的变化.
- 为了确定与Lp (a) 水平波动相关的因素.
- 挑战Lp (a) 随时间变化的最小假设.
主要方法:
- 从脂质诊所对成年患者的回顾性分析.
- 包括至少有两次Lp(a) 测量 (间隔≥4个月) 的患者.
- 计算Lp (a) 变化率作为百分比变化;超变量定义为>25%的变化.
主要成果:
- 34%的参与者 (n=61) 显示出超变的Lp (a) 水平 (>25%的变化).
- 男性的变化率略高于女性.
- 超变性患者在Lp (a) 水平上升和下降;在所有超变性女性中都观察到更年期.
结论:
- 该研究质疑仅仅依靠单个Lp (a) 测量来评估心血管风险.
- 重复Lp (a) 测量可能是有益的,尤其是边界风险病例.
- 临床实践可能需要调整以考虑到Lp (a) 的变化.
相关概念视频
Measurement of Blood Pressure
907
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
907
Special considerations while measuring blood pressure
712
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
712
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
73
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
73
Pre-Procedural Guidelines for Assessing Blood Pressure
539
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
539


